StockData
TELA Bio, Inc. logo

TELA Bio, Inc. (TELA) stock

TELANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.76+0.00 (+0.07%)

Close on Nov 17, 2026Market cap $34.21MP/E –Yield –

TELA Bio gross margin

Gross margin is gross profit as a percentage of revenue.

TELA Bio's gross margin for the twelve months ending Jun 30, 2026 was 67.8%. For fiscal 2025 it was 67.7%, against 67.1% the year before. The highest annual figure on record is 68.6% in fiscal 2023.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202567.7%+0.6
FY2024Dec 31, 202467.1%−1.5
FY2023Dec 31, 202368.6%+3.3
FY2022Dec 31, 202265.3%+1.4
FY2021Dec 31, 202163.9%+2.2
FY2020Dec 31, 202061.7%+1.7
FY2019Dec 31, 201960.0%+24.5
FY2018Dec 31, 201835.6%−24.1
FY2017Dec 31, 201759.6%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202672.3%+2.4
Q1 FY2026Mar 31, 202665.7%−1.9
Q4 FY2025Dec 31, 202565.9%+2.3
Q3 FY2025Sep 30, 202567.5%−0.3
Q2 FY2025Jun 30, 202569.8%+1.0
Q1 FY2025Mar 31, 202567.6%−0.7
Q4 FY2024Dec 31, 202463.6%−4.8
Q3 FY2024Sep 30, 202467.8%−1.2
Q2 FY2024Jun 30, 202468.8%−1.6
Q1 FY2024Mar 31, 202468.3%+2.0
Q4 FY2023Dec 31, 202368.4%−2.0
Q3 FY2023Sep 30, 202369.0%+3.4
Q2 FY2023Jun 30, 202370.4%+7.4
Q1 FY2023Mar 31, 202366.3%+5.6
Q4 FY2022Dec 31, 202270.3%+2.8
Q3 FY2022Sep 30, 202265.6%+5.5
Q2 FY2022Jun 30, 202262.9%−4.4
Q1 FY2022Mar 31, 202260.7%+1.8
Q4 FY2021Dec 31, 202167.6%+3.0
Q3 FY2021Sep 30, 202160.1%−1.7
Q2 FY2021Jun 30, 202167.3%+7.9
Q1 FY2021Mar 31, 202159.0%−0.1
Q4 FY2020Dec 31, 202064.6%+6.9
Q3 FY2020Sep 30, 202061.9%+7.5
Q2 FY2020Jun 30, 202059.5%+17.1
Q1 FY2020Mar 31, 202059.0%−2.8
Q2 FY2019Jun 30, 201957.7%–
Q1 FY2019Mar 31, 201954.4%–
Q4 FY2018Dec 31, 201842.4%–
Q3 FY2018Sep 30, 201861.8%–

More TELA Bio figures

See a number that looks wrong?